.png){kind=icon}
.png){kind=icon}
Return
Chitosan-modified liposomes for improved oral delivery of dihydromyricetin: synergistic stabilization, pH-responsive release, and markedly enhanced bioaccessibility
.png){kind=icon}
OA
AI
H
M
C
C
H
L
DOI：10.1016/j.fochx.2026.104259.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Chitosan-modified DMY liposomes showed higher encapsulation efficiency. • Chitosan boosts DMY's antioxidant activity through synergistic interactions. • Chitosan-modified liposomes presented improved stability and sustained release. • Chitosan-modified liposomes remained intact in simulated gastrointestinal digestion. • Chitosan-modified liposomes achieved 2.67× DMY bioaccessibility vs free form (9.73%).
Keywords:
Dihydromyricetin
Chitosan
Liposomes
In vitro release
Gastrointestinal digestion
Journal
IF:
8.2
Papers:
2.7K
Citations:
9.8K
Organization
No organization information available
Cited Papers